Comments 1 - 14 of 14 Search these comments
“A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a ‘game changer’ in the fight against the virus had a significantly higher risk of death compared with those who did not,” the Washington Post reports.
not peer reviewed
Would be nice to get a link to original research article, published in a peer-reviewed journal.
I certainly agree. There are good large double blind studies on going, they take time. The take away from conflicting studies is a simple one. Buyer beware. Not "what do you have to lose"
ORANGEMAN BAD, CAN NOT BE RIGHT ABOUT ANYTHING
No its just he should keep his mouth shut about things he knows nothing about, that would include all things medical.
rd6B saysORANGEMAN BAD, CAN NOT BE RIGHT ABOUT ANYTHING
No its just he should keep his mouth shut about things he knows nothing about, that would include all things medical.
Gosh, "It is relatively safe and well-tolerated" unless Trump recommends it.
And, several sites have mentioned that "After Morocco and Algeria began using HCQ, a trend break and sharp reduction in their COVID-19 case fatality rate occurred." though I haven't found links to the primary source.